CRYSTMAS study adds to concerns about renal safety and increased mortality in sepsis patients.

Crit Care · 2012 · PMC3672563 · PMID 23134688

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendP = 0.06so close (0.05 < p ≤ 0.1)

The number of subjects undergoing renal replacement therapy (RRT) doubled in the hydroxyethylstarch (HES 130/0.4) arm [ 4 ] (Table 1 ); mean duration of RRT was 9.1 days versus 4.3 days [ 4 ]; and Kaplan-Meier curves for time to RRT showed a trend against HES ( P = 0.06; Figure 1 ) [ 4 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.